Advertisement


Parenting/Child health
New Down syndrome target
Last updated: Wednesday, December 07, 2005
A molecule that may offer a target for treatment of mental impairment in people with Down syndrome has been identified by scientists at the Institute of Psychiatry at King's College London, England.

Advertisement
They found that people with Down syndrome have higher levels of the molecule myo-inositol in their brains than healthy people, and that higher levels of the molecule are associated with lower levels of intellectual ability, BBC News reported.

The study authors said they also suspect that high levels of the molecule may predispose people with Down syndrome to early-onset Alzheimer's disease. It's already known that myo-inositol promotes formation of amyloid plaques associated with Alzheimer's disease.

The findings appear in the journal Archives of General Psychiatry. – (HealthDayNews)

Read more: How doctors test your unborn baby for Down syndrome

December 2005
 
Print this article on
 Rate this article
Poor 1 2 3 4 5 Excellent

Today's top stories

 
 
Subscribe to...
*Daily tip
*Weekly tip
Want to subscribe to our newsletters?
Click here.
*Stand a chance to win R1000 every month!

 
 
 
 
Advertisement

Advertisement

 Sponsored links
 Health24 links




 

© Health24 2000-2009. All rights reserved
  
We comply with the HONcode standard for trustworthy health
information.
Verify here.